Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Sees Large Increase in Short Interest

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 100,700 shares, a growth of 15.5% from the November 15th total of 87,200 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Newron Pharmaceuticals Stock Performance

Newron Pharmaceuticals stock remained flat at $9.36 during midday trading on Friday. Newron Pharmaceuticals has a fifty-two week low of $9.10 and a fifty-two week high of $12.00. The business has a fifty day simple moving average of $9.36 and a two-hundred day simple moving average of $10.09.

Newron Pharmaceuticals Company Profile

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.